Franklin Resources
TERN

Franklin Resources’s Terns Pharmaceuticals TERN Stock Holding History

Franklin Resources’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127M Sell
2,409,019
-322,293
-12% -$13.2M 0.03% 379
2025
Q4 		$110M Buy
2,731,312
+1,453,849
+114% +$33.6M 0.03% 409
2025
Q3 		$9.59M Buy
1,277,463
+67
+0% +$428 ﹤0.01% 1177
2025
Q2 		$4.76M Buy
+1,277,396
New +$3.99M ﹤0.01% 1377
2024
Q3 		– Sell
-1,122,842
Closed -$7.65M – 3027
2024
Q2 		$7.65M Sell
1,122,842
-1,259,054
-53% -$7.63M ﹤0.01% 1170
2024
Q1 		$15.6M Buy
2,381,896
+74,062
+3% +$484K ﹤0.01% 939
2023
Q4 		$15M Buy
2,307,834
+159,013
+7% +$841K 0.01% 829
2023
Q3 		$10.8M Buy
2,148,821
+664,167
+45% +$4.21M 0.01% 898
2023
Q2 		$13M Buy
1,484,654
+27,200
+2% +$317K 0.01% 869
2023
Q1 		$17.3M Buy
1,457,454
+707,430
+94% +$6.76M 0.01% 814
2022
Q4 		$7.64M Buy
+750,024
New +$4.99M ﹤0.01% 1011

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Franklin Resources's TERN Position: Q1 2026 in Review

Franklin Resources reduced its Terns Pharmaceuticals (TERN) stake by 12% in Q1 2026, selling an estimated $13.2M and leaving 2,409,019 shares worth $127M. The position accounts for 0.03% of the portfolio, ranked #379.

Franklin Resources first reported a position in TERN in Q4 2022 and has held it in 11 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Franklin Resources held 2,409,019 shares of Terns Pharmaceuticals worth $127M as of Q1 2026.
  • Franklin Resources sold 322,293 Terns Pharmaceuticals shares in Q1 2026, an estimated $13.2M.
  • Terns Pharmaceuticals made up 0.03% of Franklin Resources's portfolio in Q1 2026, its #379 holding.
  • Franklin Resources first reported a position in Terns Pharmaceuticals in Q4 2022 and has held it in 11 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.